SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,151.04 905.01
( 1.24%)

Global Indices

Nasdaq

52,520.99 122.42
(0.23%)

Dow Jones

7,766.26 22.66
(0.29%)

Hang Seng

64,627.45 673.26
(1.05%)

Nikkei 225

10,729.94 35.44
(0.33%)

Forex

USD-INR

95.08 -0.03
(-0.03%)

EUR-INR

106.01 -0.48
(-0.45%)

GBP-INR

126.67 -0.36
(-0.28%)

JPY-INR

0.60 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

36.4616629

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

42.99

13830.56

EPS(TTM)

Face Value()

Div & Yield %

7.1

0.29

Back

Colgate-Palmolive (India) standalone net profit rises 7.01% in the June 2026 quarter

Jul 29,2026

Net profit of Colgate-Palmolive (India) rose 7.01% to Rs 343.08 crore in the quarter ended June 2026 as against Rs 320.62 crore during the previous quarter ended June 2025. Sales rose 11.96% to Rs 1590.56 crore in the quarter ended June 2026 as against Rs 1420.64 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1590.56	1420.64	12
OPM %	30.36	31.86	-
PBDT	504.74	469.49	8
PBT	465.53	431.95	8
NP	343.08	320.62	7

74,151.04 905.01 ( 1.24%)

52,520.99 122.42 (0.23%)

7,766.26 22.66 (0.29%)

64,627.45 673.26 (1.05%)

10,729.94 35.44 (0.33%)

95.08 -0.03 (-0.03%)

106.01 -0.48 (-0.45%)

126.67 -0.36 (-0.28%)

0.60 0.00 (-0.36%)